[Cerivastatin].
Nakaya
N
N
Tokyo Metropolitan National Health Insurance Organization, Fussa Hospital.
D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy; D011725:Pyridines / Q000493:pharmacokinetics / Q000627:therapeutic use; D011973:Receptors, LDL / Q000378:metabolism
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011725:Pyridines; D011973:Receptors, LDL; C086276:cerivastatin